NEUROREPLETE Trademark

Trademark Overview

On Thursday, March 6, 2003, a trademark application was filed for NEUROREPLETE with the United States Patent and Trademark Office. The USPTO has given the NEUROREPLETE trademark a serial number of 78222709. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 24, 2012. The NEUROREPLETE trademark is filed in the Pharmaceutical Products category with the following description:

Amino acids for use in the treatment of neurotransmitter dysfunction
neuroreplete

General Information

Serial Number78222709
Word MarkNEUROREPLETE
Filing DateThursday, March 6, 2003
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 24, 2012
Registration Number2973066
Registration DateTuesday, July 19, 2005
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, June 1, 2004

Trademark Statements

Goods and ServicesAmino acids for use in the treatment of neurotransmitter dysfunction

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 24, 2012
Primary Code005
First Use Anywhere DateFriday, December 7, 2001
First Use In Commerce DateFriday, February 1, 2002

Trademark Owner History

Party NameNOT AVAILABLE
Party Type30 - Original Registrant
Legal Entity Type01 - Individual
AddressDuluth, MN 55808
Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressDuluth, MN 55808
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressDuluth, MN 55808

Trademark Events

Event DateEvent Description
Friday, February 24, 2012CANCELLED SEC. 8 (6-YR)
Thursday, April 23, 2009WITHDRAWAL OF ATTORNEY GRANTED
Thursday, April 23, 2009TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Thursday, November 8, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 8, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 19, 2005REGISTERED-PRINCIPAL REGISTER
Wednesday, May 25, 2005LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, May 20, 2005ASSIGNED TO LIE
Saturday, May 14, 2005ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 23, 2005STATEMENT OF USE PROCESSING COMPLETE
Wednesday, February 23, 2005USE AMENDMENT FILED
Wednesday, February 23, 2005TEAS STATEMENT OF USE RECEIVED
Tuesday, January 18, 2005APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 27, 2004PAPER RECEIVED
Thursday, September 16, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 24, 2004NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 1, 2004PUBLISHED FOR OPPOSITION
Wednesday, May 12, 2004NOTICE OF PUBLICATION
Tuesday, March 16, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 11, 2004EXAMINERS AMENDMENT E-MAILED
Monday, February 16, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 17, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 17, 2004EMAIL RECEIVED
Tuesday, February 17, 2004EMAIL RECEIVED
Tuesday, August 19, 2003NON-FINAL ACTION E-MAILED
Tuesday, August 19, 2003ASSIGNED TO EXAMINER

Related Keywords

neuroreplete dysfunction neurotransmitter treatment acids amino